Charlotte Pilard

545 total citations
3 papers, 264 citations indexed

About

Charlotte Pilard is a scholar working on Oncology, Immunology and Clinical Biochemistry. According to data from OpenAlex, Charlotte Pilard has authored 3 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Immunology and 1 paper in Clinical Biochemistry. Recurrent topics in Charlotte Pilard's work include Cancer Immunotherapy and Biomarkers (2 papers), Adenosine and Purinergic Signaling (1 paper) and Advanced Glycation End Products research (1 paper). Charlotte Pilard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Adenosine and Purinergic Signaling (1 paper) and Advanced Glycation End Products research (1 paper). Charlotte Pilard collaborates with scholars based in Belgium. Charlotte Pilard's co-authors include Michaël Herfs, Marie Ancion, Pascale Hubert, Guy Jérusalem, Philippe Delvenne, Marie‐Julie Nokin, Coraline Radermecker, Olivier Peulen, Patrick Roncarati and Diane Bruyère and has published in prestigious journals such as British Journal of Cancer and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Charlotte Pilard

3 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte Pilard Belgium 3 126 111 79 46 39 3 264
Marie Ancion Belgium 4 128 1.0× 112 1.0× 93 1.2× 49 1.1× 41 1.1× 7 289
Alizée Lebeau Belgium 6 65 0.5× 72 0.6× 83 1.1× 39 0.8× 25 0.6× 11 212
Félicie Sherer Belgium 6 54 0.4× 46 0.4× 90 1.1× 37 0.8× 71 1.8× 7 231
Liaoran Niu China 11 100 0.8× 42 0.4× 157 2.0× 98 2.1× 71 1.8× 30 325
Emma Hajaj Israel 8 126 1.0× 84 0.8× 97 1.2× 84 1.8× 27 0.7× 8 242
Zihang Ling China 8 96 0.8× 48 0.4× 153 1.9× 101 2.2× 29 0.7× 13 291
Amy Shyu United States 2 67 0.5× 135 1.2× 142 1.8× 110 2.4× 25 0.6× 2 334
Yu P China 9 113 0.9× 139 1.3× 235 3.0× 247 5.4× 67 1.7× 20 462

Countries citing papers authored by Charlotte Pilard

Since Specialization
Citations

This map shows the geographic impact of Charlotte Pilard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Pilard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Pilard more than expected).

Fields of papers citing papers by Charlotte Pilard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Pilard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Pilard. The network helps show where Charlotte Pilard may publish in the future.

Co-authorship network of co-authors of Charlotte Pilard

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Pilard. A scholar is included among the top collaborators of Charlotte Pilard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Pilard. Charlotte Pilard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Pilard, Charlotte, Patrick Roncarati, Marie Ancion, et al.. (2025). RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells. Journal for ImmunoTherapy of Cancer. 13(3). e010753–e010753. 3 indexed citations
2.
Hubert, Pascale, Patrick Roncarati, Stéphanie Demoulin, et al.. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer. 9(3). e001966–e001966. 129 indexed citations
3.
Pilard, Charlotte, Marie Ancion, Philippe Delvenne, et al.. (2021). Cancer immunotherapy: it’s time to better predict patients’ response. British Journal of Cancer. 125(7). 927–938. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Ancion Breakdown of academic impact, for papers by Alizée Lebeau Breakdown of academic impact, for papers by Félicie Sherer Breakdown of academic impact, for papers by Liaoran Niu Breakdown of academic impact, for papers by Emma Hajaj Breakdown of academic impact, for papers by Zihang Ling Breakdown of academic impact, for papers by Amy Shyu Breakdown of academic impact, for papers by Yu P
Rankless by CCL
2026